Exploring the relationship between triglyceride-glucose index and peripheral neuropathy in Nigerian patients with type 2 diabetes: a comparison with other metabolic markers

Blessing Kenechi Myke-Mbata; Bruno Basil; Izuchukwu Nnachi Mba; Terna Gav Ambrose

doi:10.18203/2320-6012.ijrms20261313

Authors

Blessing Kenechi Myke-Mbata Department of Chemical Pathology, Rev. Fr. Moses Orshio Adasu University, Makurdi, Nigeria https://orcid.org/0000-0002-8105-3934
Bruno Basil International Institute for Pathology and Forensic Science Research, David Umahi Federal University of Health Sciences, Uburu, Nigeria
Izuchukwu Nnachi Mba Department of Chemical Pathology, Nile University, Abuja, Nigeria https://orcid.org/0000-0003-3001-1440
Terna Gav Ambrose Department of Chemical Pathology, Rev. Fr. Moses Orshio Adasu University, Makurdi, Nigeria https://orcid.org/0000-0003-4686-3867

DOI:

https://doi.org/10.18203/2320-6012.ijrms20261313

Keywords:

Diabetic peripheral neuropathy, Type 2 diabetes mellitus, Albumin-to-creatinine ratio, Apolipoprotein A-I, Nigeria, Triglyceride–glucose index

Abstract

Background: Diabetic peripheral neuropathy (DPN) is a common and disabling complication of type 2 diabetes mellitus (T2DM). The triglyceride–glucose (TyG) index, a surrogate marker of insulin resistance, has been associated with several diabetes-related complications, but its role in identifying DPN remains unclear. This study evaluated the relationship between the TyG index and DPN among Nigerian patients with T2DM and compared its performance with other metabolic markers.

Methods: This hospital-based cross-sectional study was conducted among adults with T2DM attending diabetes clinics in two tertiary hospitals in North-Central Nigeria. DPN was assessed using the Michigan Neuropathy Screening Instrument, 10-g monofilament and 128-Hz tuning fork. The TyG index, albumin–creatinine ratio (ACR), glycated haemoglobin (HbA1c), serum uric acid and apolipoprotein A-I (Apo A-I) were measured.

Results: The prevalence of DPN was 61.8% (n=63). DPN was associated with longer diabetes duration, higher hypertension prevalence, lower physical activity and worse renal indices. Participants with DPN had lower Apo A-I (p=0.013), higher urine albumin (p<0.001) and higher ACR (p<0.001). The TyG index did not differ significantly between groups (p=0.218) and showed poor diagnostic performance (AUC 0.427, p=0.218). By contrast, ACR (AUC 0.757, p<0.001) and Apo A-I (AUC 0.647, p=0.013) demonstrated better discriminatory ability.

Conclusions: TyG index showed poor diagnostic utility for DPN, whereas ACR and Apo A-I were significantly associated with neuropathy and provided superior discrimination. These findings support the use of renal and lipid-related markers alongside routine neuropathy screening.

References

Huang Q, Li Y, Yu M, Lv Z, Lu F, Xu N, et al. Global burden and risk factors of type 2 diabetes mellitus from 1990 to 2021 and forecasts to 2050. Front Endocrinol (Lausanne). 2025;14:1538143.

He Q, Wu W, Chen J, Zhou H, Ding G, Lai S, et al. Global burden of type 2 diabetes in non-elderly individuals 1990 to 2021 and projections for 2050: a systematic analysis of the 2021 Global Burden of Disease. Diabetes Metab. 2025;51(4):101660.

Ogunjobi TT, Adeyanju SA, Akinwande KG, Obasi DE, Aigbagenode AA, Musa A, et al. Improving the prevention and treatment of Lean Type 2 Diabetes in Sub-Saharan Africa: A review. Eur J Sustain Dev Res. 2025;9(2):36586.

Mohammed S, Muhammed H, Shetty TV, Shanavas S. Micro and Macrovascular Complications in Diabetes Mellitus. Yangtze Med. 2025;9(1):96-123.

Passali D, Bellussi LM, Santantonio M, Passali GC. A Structured Narrative Review of the OSA–T2DM Axis. J Clin Med. 2025;14(12):4168.

Zhu J, Hu Z, Luo Y, Liu Y, Luo W, Du X, et al. Diabetic peripheral neuropathy: pathogenetic mechanisms and treatment. Front Endocrinol (Lausanne). 2024;14:1265372.

Roy B. Pathophysiological mechanisms of diabetes-induced macrovascular and microvascular complications: the role of oxidative stress. Med Sci (Basel). 2025;13(3):87.

Miranda CS, Pinto VJ, Miranda C, Miranda Sr C, Miranda CC. Correlation of triglyceride-glucose index and the presence of microvascular complications of diabetes. Cureus. 2025;17(8):35156.

Horton WB, Love KM, Gregory JM, Liu Z, Barrett EJ. Metabolic and vascular insulin resistance: partners in the pathogenesis of cardiovascular disease in diabetes. Am J Physiol Heart Circ Physiol. 2025;328(6):1218-36.

Claudel SE, Verma A. Albuminuria in cardiovascular, kidney and metabolic disorders: a state-of-the-art review. Circulation. 2025;151(10):716-32.

Wu QY, Mo LR, Nan J, Huang WZ, Wu Q, Su Q. The association between the hemoglobin glycation index and cardiometabolic diseases: a mini‐review. J Clin Hypertens (Greenwich). 2025;27(7):70092.

Liu Y, Li Z, Xu Y, Mao H, Huang N. Uric Acid and Atherosclerosis in Patients with Chronic Kidney Disease: Recent Progress, Mechanisms and Prospect. Kidney Dis (Basel). 2025;11(1):112-27.

Hosogai M, Matsushige T, Tsuchigauchi S, Takahashi H, Oku S, Horie N. Apolipoprotein A1 levels are inversely associated with aneurysm wall enhancement in unruptured intracranial aneurysms. Neurol Med Chir (Tokyo). 2025;65(1):1-7.

Rivera-Caravaca JM, Soler-Espejo E, Ramos-Bratos MP, López-Gálvez R, González-Lozano E, Lip GY, et al. The triglyceride-glucose index, a marker of insulin resistance, as a predictor of thrombotic risk in atrial fibrillation. Cardiovasc Diabetol. 2025;24(1):281.

Zhuang J, Qiu S, Fang T, Ding M, Chen M. Association Between Triglyceride Glucose Index and Risk of Carotid Plaques in Asia: A Systematic Review and Meta-Analysis. Horm Metab Res. 2025;57(4):252-61.

Saenz C, Carracedo S. The revision of the Declaration of Helsinki viewed from the Americas—paving the way to better research. JAMA. 2025;333(1):24-5.

Ikem RT, Enikuomehin AC, Soyoye DO, Kolawole BA. The burden of diabetic complications in subjects with type 2 diabetes attending the diabetes clinic of the Obafemi Awolowo University Teaching Hospital, Ile-Ife, Nigeria - a cross-sectional study. Pan Afr Med J. 2022;43:148.

Althubaiti A. Sample size determination: A practical guide for health researchers. J Gen Fam Med. 2022;24(2):72-8.

American Diabetes Association. Diagnosis and classification of diabetes: standards of care in diabetes—2025. Diabetes Care. 2025;48(1):27-49.

Rule AD, Waller DC, Helgeson ES, Chamberlain AM, Saiki AC, de Abreu ES, et al. Trends in the Incidence of Hypertension Among Healthy Adults Across 6 Decades. Mayo Clin Proc. 2025;100(5):778-89.

Rong L, Hou N, Hu J, Gong Y, Yan S, Li C, et al. The role of TyG index in predicting the incidence of diabetes in Chinese elderly men: a 20-year retrospective study. Front Endocrinol (Lausanne). 2023;14:1191090.

Résimont G, Vranken L, Pottel H, Jouret F, Krzesinski JM, Cavalier E, et al. Estimating urine albumin to creatinine ratio from protein to creatinine ratio using same day measurement: validation of equations. Clin Chem Lab Med. 2022;60(7):1064-72.

Wang M, Hng TM. HbA1c: More than just a number. Aust J Gen Pract. 2021;50(9):628-32.

Viswanathan V, Ahmed Khan B, Nachimuthu S, Kumpatla S. Precision of Michigan neuropathy screening instrument (MNSI) tool for the diagnosis of diabetic peripheral neuropathy among people with type 2 diabetes—a study from South India. Int J Low Extrem Wounds. 2023;15:13209.

Zhang H, Yang S, Wang H, Fareeduddin Mohammed Farooqui H, Zhu W, Niu T, et al. Assessing the diagnostic utility of urinary albumin-to-creatinine ratio as a potential biomarker for diabetic peripheral neuropathy in type 2 diabetes mellitus patients. Sci Rep. 2024;14(1):27198.

Fukuda T, Fujii A, Akihisa T, Otsubo N, Murakami M, Yamada T, et al. Association between diabetic peripheral neuropathy as measured using a point-of-care sural nerve conduction device and urinary albumin excretion in patients with type 2 diabetes. J Clin Med. 2023;12(12):4089.

King TW, Cochran BJ, Rye KA. ApoA-I and diabetes. Arterioscler Thromb Vasc Biol. 2023;43(8):1362–8.

Li X, Huang B, Liu Y, Wang M, Cui JQ. Uric acid in diabetic microvascular complications: mechanisms and therapy. J Diabetes Complications. 2025;39(2):108929.

Myke-Mbata BK, Meludu SC, Ochalefu DO, Basil BC. Comparison of the diagnostic relevance of albumin creatinine ratio versus cystatin C in assessment of cardiovascular complication in type 2 diabetics. West Afr J Med. 2021;38(4):328–34.

Tu Z, Du J, Ge X, Peng W, Shen L, Xia L, et al. Triglyceride glucose index for the detection of diabetic kidney disease and diabetic peripheral neuropathy in hospitalized patients with type 2 diabetes. Diabetes Ther Res Treat Educ Diabetes Relat Disord. 2024;15(8):1799–810.

Miao Y, Wang Y, Wang Y, Yan P, Chen Z, Wan Q. The association between triglyceride-glucose index and its combination with obesity indicators and lower extremity peripheral artery disease in patients with type 2 diabetes mellitus: a cross-sectional study. Diabetes Metab Syndr Obes. 2024;17:2607–17.

Shiferaw WS, Akalu TY, Worku Y, Aynalem YA. Prevalence of diabetic peripheral neuropathy in Africa: a systematic review and meta-analysis. BMC Endocr Disord. 2020;20(1):49.

Azeez T, Eguzozie E, Olalusi O. Diabetic peripheral neuropathy: a systematic review of Nigerian patients. Libyan Int Med Univ J. 2021;6(1):12–8.

Kwak J, Han KD, Lee EY, Lee SH, Lim DJ, Kwon HS, et al. Association between the Triglyceride-Glucose Index and Cardiovascular Risk and Mortality across Different Diabetes Durations: A Nationwide Cohort Study. Endocrinol Metab (Seoul). 2025;40(4):548-60.

Nanda R, Patel S, Ghosh A, Asha KS, Mohapatra E. A study of apolipoprotein A1 (ApoA1) and interleukin-10 (IL-10) in diabetes with foot ulcers. BioMedicine. 2022;12(1):30–8.

Kaewput W, Thongprayoon C, Rangsin R, Jindarat S, Narindrarangkura P, Bathini T, et al. The association between serum uric acid and peripheral neuropathy in patients with type 2 diabetes mellitus: a multicenter nationwide cross-sectional study. Korean J Fam Med. 2020;41(3):189–94.

Zhuang Y, Huang H, Hu X, Zhang J, Cai Q. Serum uric acid and diabetic peripheral neuropathy: a double-edged sword. Acta Neurol Belg. 2023;123(3):857–63.

Mba IN, Basil B, Myke-Mbata B, Olayanju OA, Okpara IC, Adebisi SA. Serum high-sensitivity C-reactive protein and uric acid as biomarkers of left ventricular hypertrophy in hypertensive patients in Makurdi, Nigeria. Afr J Biomed Res. 2023;26(1):25–9.

Barzilay JI, Farag YMK, Durthaler J. Albuminuria: an underappreciated risk factor for cardiovascular disease. J Am Heart Assoc. 2024;13(2):30131.